BLFSNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
BIOLIFE SOLUTIONS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$38.61+0.00 (0.00%)
Close on Oct 7, 2026
- Market cap
- $1.90B
- P/E (TTM)
- 33.6
- Dividend yield
- –
Biolife Solutions statistics
Financials through Jun 30, 2026, price-based ratios appear once a share price is available, median of Electromedical & Electrotherapeutic Apparatus companies for comparison
Income (trailing twelve months)
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Revenue | $102.82M | $102.39M |
| Operating Income | $2.98M | -$4.31M |
| Pretax Income | $8.07M | -$2.26M |
| Net Income | $57.98M | -$6.57M |
| EBITDA | $4.66M | -$1.98M |
| EPS (Diluted) | $1.15 | -$0.07 |
Margins
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Operating Margin | 2.90% | -6.04% |
| Pretax Margin | 7.84% | -4.11% |
| Profit Margin | 56.4% | -10.5% |
| EBITDA Margin | 4.54% | -2.67% |
Returns
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Return on Equity (ROE) | 15.1% | -19.2% |
| Return on Assets (ROA) | 13.9% | -13.3% |
| Return on Invested Capital (ROIC) | 1.06% | -4.11% |
| Return on Capital Employed (ROCE) | 0.69% | -9.07% |
Growth
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 25.4% | 8.85% |
| Revenue Growth (3Y CAGR) | 8.07% | 7.08% |
| Revenue Growth (5Y CAGR) | 14.9% | 11.8% |
Balance sheet
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $113.10M | $37.33M |
| Total Debt | $0 | $72.66M |
| Net Cash (Debt) | $113.10M | $3.92M |
| Net Cash Per Share | $2.31 | $0.28 |
| Equity (Book Value) | $420.00M | $57.36M |
| Book Value Per Share | $8.59 | $2.81 |
| Tangible Book Value | $207.76M | $10.71M |
| Working Capital | $121.25M | $54.64M |
Financial position
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Current Ratio | 9.69 | 2.50 |
| Quick Ratio | 8.87 | 1.54 |
| Debt / Equity | 0.00 | 0.38 |
| Debt / EBITDA | 0.00 | 2.31 |
| Net Debt / EBITDA | -24.25 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Operating Cash Flow | $16.88M | -$653.46K |
Efficiency
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Asset Turnover | 0.25 | 0.59 |
| Revenue Per Employee | $663.34K | $322.75K |
| Profits Per Employee | $374.07K | -$52.11K |
| Employee Count | 155 | 197 |
Shares
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Shares Outstanding | 48,906,700 | 44,856,700 |
| Shares Change (YoY) | 5.28% | 3.35% |
| Shares Change (QoQ) | 0.13% | 0.27% |
| Float | 46,957,900 | 36,934,400 |
| Shares Held by Insiders | 3.98% | 10.6% |
| Shares Held by Institutions | 101.1% | 63.5% |
Taxes
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Income Tax | -$42.38M | $1.52M |
| Effective Tax Rate | -525.4% | 18.6% |
Scores
| Measure | Biolife Solutions | Industry median |
|---|---|---|
| Graham Number | $14.91 | $34.37 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -2.29 | -2.64 |
Calculated by StockData from Biolife Solutions's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.